Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

Healthcare Medical Devices
MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

MedMira Inc
Bullboard Posts
User Avatar Image
(0)
•••
Post by OPFundon May 19, 2009 1:51pm
248 Views
Post# 16001276

US Patent

US Patent

This is from 2008 Annual report:

Research & Development - MedMira’s research team made further advancements on the Company’s
product pipeline and continued to evolve our patented technology platform upon which we build our
rapid diagnostic tests. During this quarter we moved several new rapid test applications for infectious
diseases and sexually transmitted diseases through the final stages of discovery and development,
readying them for the next stage of commercialization.
The research team has been continuously working on enhancements to MedMira’s rapid flow-through
technology (RFT) platform and during the third quarter filed a new patent application in the United States
to protect the latest version of the RFT.

Patent application is filed in the United States for MedMira’s next generation diagnostics technology
platform which will enable an even simpler, user-friendly testing procedure

Medmira does not show the names or reference #'s of the patents it holds

OP

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities